The data demonstrated that AKT activation augmented the metastatic and invasive capacity of HCC cells that were attenuated by si-DNMT3A (***p<0.001, **p<0.01, Figure 9C, 9D). This evidence concerns the gene AKT1 and hepatocellular carcinoma.